0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Weight-loss Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-30F1883
Home | Market Reports | Health| Pharmacy
Global Weight Loss Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Weight-loss Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-30F1883
Report
October 2024
Pages:133
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Weight-loss Drugs - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Weight-loss Drugs - Market

Weight-loss Drugs - Market

The global market for Weight-loss Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Weight-loss Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Weight-loss Drugs by region & country, by Type, and by Application.
The Weight-loss Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Weight-loss Drugs.
Market Segmentation

Scope of Weight-loss Drugs - Market Report

Report Metric Details
Report Name Weight-loss Drugs - Market
CAGR 5%
Segment by Type:
  • Liquid
  • Powder
  • Softgels
  • Pills
  • Others
Segment by Application
  • Online Sales
  • Hospitals and Clinics
  • Pharmacy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novo Nordisk, Currax, Ultimate life ltd, Wolfson Berg Ltd, Swiss Research Labs Ltd., Roar Ambition, Health and Nutrition Ltd., Abbott, Kellogg Company, Glanbia PLC, Ajinomoto Co. Inc., Kraft Heinz Company, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., PepsiCo, Nestle, Amway Corp.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Weight-loss Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Weight-loss Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Weight-loss Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Weight-loss Drugs - Market report?

Ans: The main players in the Weight-loss Drugs - Market are Novo Nordisk, Currax, Ultimate life ltd, Wolfson Berg Ltd, Swiss Research Labs Ltd., Roar Ambition, Health and Nutrition Ltd., Abbott, Kellogg Company, Glanbia PLC, Ajinomoto Co. Inc., Kraft Heinz Company, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., PepsiCo, Nestle, Amway Corp.

What are the Application segmentation covered in the Weight-loss Drugs - Market report?

Ans: The Applications covered in the Weight-loss Drugs - Market report are Online Sales, Hospitals and Clinics, Pharmacy, Others

What are the Type segmentation covered in the Weight-loss Drugs - Market report?

Ans: The Types covered in the Weight-loss Drugs - Market report are Liquid, Powder, Softgels, Pills, Others

1 Market Overview
1.1 Weight-loss Drugs Product Introduction
1.2 Global Weight-loss Drugs Market Size Forecast
1.2.1 Global Weight-loss Drugs Sales Value (2019-2030)
1.2.2 Global Weight-loss Drugs Sales Volume (2019-2030)
1.2.3 Global Weight-loss Drugs Sales Price (2019-2030)
1.3 Weight-loss Drugs Market Trends & Drivers
1.3.1 Weight-loss Drugs Industry Trends
1.3.2 Weight-loss Drugs Market Drivers & Opportunity
1.3.3 Weight-loss Drugs Market Challenges
1.3.4 Weight-loss Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Weight-loss Drugs Players Revenue Ranking (2023)
2.2 Global Weight-loss Drugs Revenue by Company (2019-2024)
2.3 Global Weight-loss Drugs Players Sales Volume Ranking (2023)
2.4 Global Weight-loss Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Weight-loss Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Weight-loss Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Weight-loss Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Weight-loss Drugs
2.9 Weight-loss Drugs Market Competitive Analysis
2.9.1 Weight-loss Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Weight-loss Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight-loss Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Liquid
3.1.2 Powder
3.1.3 Softgels
3.1.4 Pills
3.1.5 Others
3.2 Global Weight-loss Drugs Sales Value by Type
3.2.1 Global Weight-loss Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Weight-loss Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Weight-loss Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Weight-loss Drugs Sales Volume by Type
3.3.1 Global Weight-loss Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Weight-loss Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Weight-loss Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Weight-loss Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Online Sales
4.1.2 Hospitals and Clinics
4.1.3 Pharmacy
4.1.4 Others
4.2 Global Weight-loss Drugs Sales Value by Application
4.2.1 Global Weight-loss Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Weight-loss Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Weight-loss Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Weight-loss Drugs Sales Volume by Application
4.3.1 Global Weight-loss Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Weight-loss Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Weight-loss Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Weight-loss Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Weight-loss Drugs Sales Value by Region
5.1.1 Global Weight-loss Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Weight-loss Drugs Sales Value by Region (2019-2024)
5.1.3 Global Weight-loss Drugs Sales Value by Region (2025-2030)
5.1.4 Global Weight-loss Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Weight-loss Drugs Sales Volume by Region
5.2.1 Global Weight-loss Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Weight-loss Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Weight-loss Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Weight-loss Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Weight-loss Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Weight-loss Drugs Sales Value, 2019-2030
5.4.2 North America Weight-loss Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Weight-loss Drugs Sales Value, 2019-2030
5.5.2 Europe Weight-loss Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Weight-loss Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Weight-loss Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Weight-loss Drugs Sales Value, 2019-2030
5.7.2 South America Weight-loss Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Weight-loss Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Weight-loss Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Weight-loss Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Weight-loss Drugs Sales Value
6.2.1 Key Countries/Regions Weight-loss Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Weight-loss Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Weight-loss Drugs Sales Value, 2019-2030
6.3.2 United States Weight-loss Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Weight-loss Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Weight-loss Drugs Sales Value, 2019-2030
6.4.2 Europe Weight-loss Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Weight-loss Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Weight-loss Drugs Sales Value, 2019-2030
6.5.2 China Weight-loss Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Weight-loss Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Weight-loss Drugs Sales Value, 2019-2030
6.6.2 Japan Weight-loss Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Weight-loss Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Weight-loss Drugs Sales Value, 2019-2030
6.7.2 South Korea Weight-loss Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Weight-loss Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Weight-loss Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Weight-loss Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Weight-loss Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Weight-loss Drugs Sales Value, 2019-2030
6.9.2 India Weight-loss Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Weight-loss Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Information
7.1.2 Novo Nordisk Introduction and Business Overview
7.1.3 Novo Nordisk Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Novo Nordisk Weight-loss Drugs Product Offerings
7.1.5 Novo Nordisk Recent Development
7.2 Currax
7.2.1 Currax Company Information
7.2.2 Currax Introduction and Business Overview
7.2.3 Currax Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Currax Weight-loss Drugs Product Offerings
7.2.5 Currax Recent Development
7.3 Ultimate life ltd
7.3.1 Ultimate life ltd Company Information
7.3.2 Ultimate life ltd Introduction and Business Overview
7.3.3 Ultimate life ltd Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Ultimate life ltd Weight-loss Drugs Product Offerings
7.3.5 Ultimate life ltd Recent Development
7.4 Wolfson Berg Ltd
7.4.1 Wolfson Berg Ltd Company Information
7.4.2 Wolfson Berg Ltd Introduction and Business Overview
7.4.3 Wolfson Berg Ltd Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Wolfson Berg Ltd Weight-loss Drugs Product Offerings
7.4.5 Wolfson Berg Ltd Recent Development
7.5 Swiss Research Labs Ltd.
7.5.1 Swiss Research Labs Ltd. Company Information
7.5.2 Swiss Research Labs Ltd. Introduction and Business Overview
7.5.3 Swiss Research Labs Ltd. Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Swiss Research Labs Ltd. Weight-loss Drugs Product Offerings
7.5.5 Swiss Research Labs Ltd. Recent Development
7.6 Roar Ambition
7.6.1 Roar Ambition Company Information
7.6.2 Roar Ambition Introduction and Business Overview
7.6.3 Roar Ambition Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Roar Ambition Weight-loss Drugs Product Offerings
7.6.5 Roar Ambition Recent Development
7.7 Health and Nutrition Ltd.
7.7.1 Health and Nutrition Ltd. Company Information
7.7.2 Health and Nutrition Ltd. Introduction and Business Overview
7.7.3 Health and Nutrition Ltd. Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Health and Nutrition Ltd. Weight-loss Drugs Product Offerings
7.7.5 Health and Nutrition Ltd. Recent Development
7.8 Abbott
7.8.1 Abbott Company Information
7.8.2 Abbott Introduction and Business Overview
7.8.3 Abbott Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Abbott Weight-loss Drugs Product Offerings
7.8.5 Abbott Recent Development
7.9 Kellogg Company
7.9.1 Kellogg Company Company Information
7.9.2 Kellogg Company Introduction and Business Overview
7.9.3 Kellogg Company Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Kellogg Company Weight-loss Drugs Product Offerings
7.9.5 Kellogg Company Recent Development
7.10 Glanbia PLC
7.10.1 Glanbia PLC Company Information
7.10.2 Glanbia PLC Introduction and Business Overview
7.10.3 Glanbia PLC Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Glanbia PLC Weight-loss Drugs Product Offerings
7.10.5 Glanbia PLC Recent Development
7.11 Ajinomoto Co. Inc.
7.11.1 Ajinomoto Co. Inc. Company Information
7.11.2 Ajinomoto Co. Inc. Introduction and Business Overview
7.11.3 Ajinomoto Co. Inc. Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Ajinomoto Co. Inc. Weight-loss Drugs Product Offerings
7.11.5 Ajinomoto Co. Inc. Recent Development
7.12 Kraft Heinz Company
7.12.1 Kraft Heinz Company Company Information
7.12.2 Kraft Heinz Company Introduction and Business Overview
7.12.3 Kraft Heinz Company Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Kraft Heinz Company Weight-loss Drugs Product Offerings
7.12.5 Kraft Heinz Company Recent Development
7.13 GlaxoSmithKline PLC
7.13.1 GlaxoSmithKline PLC Company Information
7.13.2 GlaxoSmithKline PLC Introduction and Business Overview
7.13.3 GlaxoSmithKline PLC Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.13.4 GlaxoSmithKline PLC Weight-loss Drugs Product Offerings
7.13.5 GlaxoSmithKline PLC Recent Development
7.14 Herbalife Nutrition Ltd.
7.14.1 Herbalife Nutrition Ltd. Company Information
7.14.2 Herbalife Nutrition Ltd. Introduction and Business Overview
7.14.3 Herbalife Nutrition Ltd. Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Herbalife Nutrition Ltd. Weight-loss Drugs Product Offerings
7.14.5 Herbalife Nutrition Ltd. Recent Development
7.15 PepsiCo
7.15.1 PepsiCo Company Information
7.15.2 PepsiCo Introduction and Business Overview
7.15.3 PepsiCo Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.15.4 PepsiCo Weight-loss Drugs Product Offerings
7.15.5 PepsiCo Recent Development
7.16 Nestle
7.16.1 Nestle Company Information
7.16.2 Nestle Introduction and Business Overview
7.16.3 Nestle Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Nestle Weight-loss Drugs Product Offerings
7.16.5 Nestle Recent Development
7.17 Amway Corp.
7.17.1 Amway Corp. Company Information
7.17.2 Amway Corp. Introduction and Business Overview
7.17.3 Amway Corp. Weight-loss Drugs Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Amway Corp. Weight-loss Drugs Product Offerings
7.17.5 Amway Corp. Recent Development
8 Industry Chain Analysis
8.1 Weight-loss Drugs Industrial Chain
8.2 Weight-loss Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Weight-loss Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Weight-loss Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Weight-loss Drugs Market Trends
    Table 2. Weight-loss Drugs Market Drivers & Opportunity
    Table 3. Weight-loss Drugs Market Challenges
    Table 4. Weight-loss Drugs Market Restraints
    Table 5. Global Weight-loss Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Weight-loss Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Weight-loss Drugs Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Weight-loss Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Weight-loss Drugs Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Weight-loss Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Weight-loss Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Weight-loss Drugs
    Table 13. Global Weight-loss Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight-loss Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Weight-loss Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Weight-loss Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Weight-loss Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Weight-loss Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Weight-loss Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Weight-loss Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Weight-loss Drugs Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Weight-loss Drugs Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Weight-loss Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Weight-loss Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Weight-loss Drugs Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Weight-loss Drugs Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Weight-loss Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Weight-loss Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Weight-loss Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Weight-loss Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Weight-loss Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Weight-loss Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Weight-loss Drugs Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Weight-loss Drugs Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Weight-loss Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Weight-loss Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Weight-loss Drugs Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Weight-loss Drugs Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Weight-loss Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Weight-loss Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Weight-loss Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Weight-loss Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Weight-loss Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Weight-loss Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Weight-loss Drugs Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Weight-loss Drugs Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Weight-loss Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Weight-loss Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Weight-loss Drugs Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Weight-loss Drugs Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Weight-loss Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Weight-loss Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Weight-loss Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Weight-loss Drugs Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Weight-loss Drugs Sales Volume, (2025-2030) & (K Units)
    Table 57. Novo Nordisk Company Information
    Table 58. Novo Nordisk Introduction and Business Overview
    Table 59. Novo Nordisk Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Novo Nordisk Weight-loss Drugs Product Offerings
    Table 61. Novo Nordisk Recent Development
    Table 62. Currax Company Information
    Table 63. Currax Introduction and Business Overview
    Table 64. Currax Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Currax Weight-loss Drugs Product Offerings
    Table 66. Currax Recent Development
    Table 67. Ultimate life ltd Company Information
    Table 68. Ultimate life ltd Introduction and Business Overview
    Table 69. Ultimate life ltd Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Ultimate life ltd Weight-loss Drugs Product Offerings
    Table 71. Ultimate life ltd Recent Development
    Table 72. Wolfson Berg Ltd Company Information
    Table 73. Wolfson Berg Ltd Introduction and Business Overview
    Table 74. Wolfson Berg Ltd Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Wolfson Berg Ltd Weight-loss Drugs Product Offerings
    Table 76. Wolfson Berg Ltd Recent Development
    Table 77. Swiss Research Labs Ltd. Company Information
    Table 78. Swiss Research Labs Ltd. Introduction and Business Overview
    Table 79. Swiss Research Labs Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Swiss Research Labs Ltd. Weight-loss Drugs Product Offerings
    Table 81. Swiss Research Labs Ltd. Recent Development
    Table 82. Roar Ambition Company Information
    Table 83. Roar Ambition Introduction and Business Overview
    Table 84. Roar Ambition Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Roar Ambition Weight-loss Drugs Product Offerings
    Table 86. Roar Ambition Recent Development
    Table 87. Health and Nutrition Ltd. Company Information
    Table 88. Health and Nutrition Ltd. Introduction and Business Overview
    Table 89. Health and Nutrition Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Health and Nutrition Ltd. Weight-loss Drugs Product Offerings
    Table 91. Health and Nutrition Ltd. Recent Development
    Table 92. Abbott Company Information
    Table 93. Abbott Introduction and Business Overview
    Table 94. Abbott Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Abbott Weight-loss Drugs Product Offerings
    Table 96. Abbott Recent Development
    Table 97. Kellogg Company Company Information
    Table 98. Kellogg Company Introduction and Business Overview
    Table 99. Kellogg Company Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Kellogg Company Weight-loss Drugs Product Offerings
    Table 101. Kellogg Company Recent Development
    Table 102. Glanbia PLC Company Information
    Table 103. Glanbia PLC Introduction and Business Overview
    Table 104. Glanbia PLC Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Glanbia PLC Weight-loss Drugs Product Offerings
    Table 106. Glanbia PLC Recent Development
    Table 107. Ajinomoto Co. Inc. Company Information
    Table 108. Ajinomoto Co. Inc. Introduction and Business Overview
    Table 109. Ajinomoto Co. Inc. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Ajinomoto Co. Inc. Weight-loss Drugs Product Offerings
    Table 111. Ajinomoto Co. Inc. Recent Development
    Table 112. Kraft Heinz Company Company Information
    Table 113. Kraft Heinz Company Introduction and Business Overview
    Table 114. Kraft Heinz Company Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Kraft Heinz Company Weight-loss Drugs Product Offerings
    Table 116. Kraft Heinz Company Recent Development
    Table 117. GlaxoSmithKline PLC Company Information
    Table 118. GlaxoSmithKline PLC Introduction and Business Overview
    Table 119. GlaxoSmithKline PLC Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. GlaxoSmithKline PLC Weight-loss Drugs Product Offerings
    Table 121. GlaxoSmithKline PLC Recent Development
    Table 122. Herbalife Nutrition Ltd. Company Information
    Table 123. Herbalife Nutrition Ltd. Introduction and Business Overview
    Table 124. Herbalife Nutrition Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Herbalife Nutrition Ltd. Weight-loss Drugs Product Offerings
    Table 126. Herbalife Nutrition Ltd. Recent Development
    Table 127. PepsiCo Company Information
    Table 128. PepsiCo Introduction and Business Overview
    Table 129. PepsiCo Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. PepsiCo Weight-loss Drugs Product Offerings
    Table 131. PepsiCo Recent Development
    Table 132. Nestle Company Information
    Table 133. Nestle Introduction and Business Overview
    Table 134. Nestle Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Nestle Weight-loss Drugs Product Offerings
    Table 136. Nestle Recent Development
    Table 137. Amway Corp. Company Information
    Table 138. Amway Corp. Introduction and Business Overview
    Table 139. Amway Corp. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Amway Corp. Weight-loss Drugs Product Offerings
    Table 141. Amway Corp. Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Weight-loss Drugs Downstream Customers
    Table 145. Weight-loss Drugs Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Weight-loss Drugs Product Picture
    Figure 2. Global Weight-loss Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Weight-loss Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Weight-loss Drugs Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Weight-loss Drugs Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Weight-loss Drugs Report Years Considered
    Figure 7. Global Weight-loss Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Weight-loss Drugs Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Weight-loss Drugs Revenue in 2023
    Figure 10. Weight-loss Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Liquid Picture
    Figure 12. Powder Picture
    Figure 13. Softgels Picture
    Figure 14. Pills Picture
    Figure 15. Others Picture
    Figure 16. Global Weight-loss Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Weight-loss Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Global Weight-loss Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 19. Global Weight-loss Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 20. Global Weight-loss Drugs Price by Type (2019-2030) & (US$/Unit)
    Figure 21. Product Picture of Online Sales
    Figure 22. Product Picture of Hospitals and Clinics
    Figure 23. Product Picture of Pharmacy
    Figure 24. Product Picture of Others
    Figure 25. Global Weight-loss Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 26. Global Weight-loss Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 27. Global Weight-loss Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 28. Global Weight-loss Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 29. Global Weight-loss Drugs Price by Application (2019-2030) & (US$/Unit)
    Figure 30. North America Weight-loss Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 31. North America Weight-loss Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 32. Europe Weight-loss Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 33. Europe Weight-loss Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 34. Asia Pacific Weight-loss Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Weight-loss Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 36. South America Weight-loss Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 37. South America Weight-loss Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 38. Middle East & Africa Weight-loss Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 39. Middle East & Africa Weight-loss Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 40. Key Countries/Regions Weight-loss Drugs Sales Value (%), (2019-2030)
    Figure 41. Key Countries/Regions Weight-loss Drugs Sales Volume (%), (2019-2030)
    Figure 42. United States Weight-loss Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 43. United States Weight-loss Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 44. United States Weight-loss Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 45. Europe Weight-loss Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Europe Weight-loss Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 47. Europe Weight-loss Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 48. China Weight-loss Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 49. China Weight-loss Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 50. China Weight-loss Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 51. Japan Weight-loss Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 52. Japan Weight-loss Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 53. Japan Weight-loss Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 54. South Korea Weight-loss Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 55. South Korea Weight-loss Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 56. South Korea Weight-loss Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 57. Southeast Asia Weight-loss Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 58. Southeast Asia Weight-loss Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 59. Southeast Asia Weight-loss Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 60. India Weight-loss Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 61. India Weight-loss Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 62. India Weight-loss Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 63. Weight-loss Drugs Industrial Chain
    Figure 64. Weight-loss Drugs Manufacturing Cost Structure
    Figure 65. Channels of Distribution (Direct Sales, and Distribution)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS